1. Home
  2. CTOR vs CTMX Comparison

CTOR vs CTMX Comparison

Compare CTOR & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTOR
  • CTMX
  • Stock Information
  • Founded
  • CTOR 2021
  • CTMX 2008
  • Country
  • CTOR United States
  • CTMX United States
  • Employees
  • CTOR N/A
  • CTMX N/A
  • Industry
  • CTOR
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTOR
  • CTMX Health Care
  • Exchange
  • CTOR NYSE
  • CTMX Nasdaq
  • Market Cap
  • CTOR 89.9M
  • CTMX 85.3M
  • IPO Year
  • CTOR N/A
  • CTMX 2015
  • Fundamental
  • Price
  • CTOR $1.18
  • CTMX $0.84
  • Analyst Decision
  • CTOR Strong Buy
  • CTMX Buy
  • Analyst Count
  • CTOR 2
  • CTMX 6
  • Target Price
  • CTOR $4.50
  • CTMX $5.77
  • AVG Volume (30 Days)
  • CTOR 85.3K
  • CTMX 847.0K
  • Earning Date
  • CTOR 02-21-2025
  • CTMX 03-10-2025
  • Dividend Yield
  • CTOR N/A
  • CTMX N/A
  • EPS Growth
  • CTOR N/A
  • CTMX N/A
  • EPS
  • CTOR N/A
  • CTMX 0.16
  • Revenue
  • CTOR N/A
  • CTMX $126,617,000.00
  • Revenue This Year
  • CTOR N/A
  • CTMX $22.55
  • Revenue Next Year
  • CTOR N/A
  • CTMX N/A
  • P/E Ratio
  • CTOR N/A
  • CTMX $5.20
  • Revenue Growth
  • CTOR N/A
  • CTMX 33.66
  • 52 Week Low
  • CTOR $0.85
  • CTMX $0.79
  • 52 Week High
  • CTOR $49.00
  • CTMX $5.85
  • Technical
  • Relative Strength Index (RSI)
  • CTOR N/A
  • CTMX 45.15
  • Support Level
  • CTOR N/A
  • CTMX $0.82
  • Resistance Level
  • CTOR N/A
  • CTMX $0.98
  • Average True Range (ATR)
  • CTOR 0.00
  • CTMX 0.06
  • MACD
  • CTOR 0.00
  • CTMX 0.01
  • Stochastic Oscillator
  • CTOR 0.00
  • CTMX 33.58

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: